Could Fampridine Attenuate the Severity of COVID-19 in Patients with Multiple Sclerosis?

Authors

  • Abdorreza Naser Moghadasi Multiple Sclerosis Research Center, Neuroscience Institute, Tehran University of Medical Sciences, Tehran, Iran.
  • Nassim Anjidani Medical Department, Orchid Pharmed Company, Tehran, Iran.
  • Fereshteh Rashvand OrchidLife Patient Support Service, Orchid Pharmed, Tehran, Iran.

DOI:

https://doi.org/10.18502/fem.v5i3.5888

Abstract

The article's abstract is not available.  

Downloads

Published

2021-04-04

Issue

Volume (5) issue (3)

Section

Articles